Apellis Pharmaceuticals, Inc. (APLS)
22.98
+0.15
(+0.66%)
USD |
NASDAQ |
Feb 10, 10:03
Apellis Pharmaceuticals Accounts Payable (Quarterly) : 38.60M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 266.36M |
| Alnylam Pharmaceuticals, Inc. | 117.59M |
| Amicus Therapeutics, Inc. | 19.10M |
| Ionis Pharmaceuticals, Inc. | 14.33M |
| Sarepta Therapeutics, Inc. | 94.02M |